News Image

C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors

Provided By GlobeNewswire

Last update: Nov 20, 2024

Hoerter Brings Over Three Decades of Oncology Commercialization and Leadership Experience

Appointment Underscores Continued Transformation of Board to Lead C4T into Next Phase of Pipeline Progress

Read more at globenewswire.com

C4 THERAPEUTICS INC

NASDAQ:CCCC (2/21/2025, 8:05:56 PM)

After market: 3.01 0 (0%)

3.01

+0.02 (+0.67%)



Find more stocks in the Stock Screener

Follow ChartMill for more